New hope for stubborn esophageal cancer: radiation boost added to drug combo
NCT ID NCT07272291
Summary
This study tests whether adding low-dose radiation to immunotherapy and chemotherapy before surgery helps patients with esophageal squamous cell carcinoma who didn't respond well to previous treatment. About 48 participants will receive radiation followed by two cycles of drug treatment, then undergo surgery. After surgery, most patients will continue taking one of the drugs for up to a year to help prevent the cancer from returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.